{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:53:07Z","timestamp":1771023187280,"version":"3.50.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nerv Ment Dis"],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The underlying mechanism of modified electroconvulsive therapy (MECT) treatment for drug-resistant and catatonic schizophrenia remains unclear. Here, we aim to investigate whether MECT exerts its antipsychotic effects through elevating <jats:italic toggle=\"yes\">N<\/jats:italic>-acetylaspartate (NAA) concentration measured by proton magnetic resonance spectroscopy (<jats:sup>1<\/jats:sup>H-MRS). Multiple-voxel <jats:sup>1<\/jats:sup>H-MRS was acquired in the bilateral prefrontal cortex (PFC) and thalamus to obtain measures of neurochemistry in 32 MECT, 34 atypical antipsychotic-treated schizophrenic patients, and 34 healthy controls. We found that both MECT and atypical antipsychotic treatments showed significant antipsychotic efficacy. MECT and atypical antipsychotic treatments reversed the reduced NAA\/creatine ratio (NAA\/Cr) in the left PFC and left thalamus in schizophrenic patients compared with healthy controls. Furthermore, the NAA\/Cr ratio after treatments was significant higher in the MECT group, but not in the medication group. Our findings demonstrate that eight times of MECT elevated the relative NAA concentration to display neuroprotective effect, which may be the underlying mechanism of rapid antipsychotic efficacy.<\/jats:p>","DOI":"10.1097\/nmd.0000000000000652","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T21:17:58Z","timestamp":1487279878000},"page":"480-486","source":"Crossref","is-referenced-by-count":18,"title":["Neuroprotective Effect of Modified Electroconvulsive Therapy for Schizophrenia"],"prefix":"10.1097","volume":"205","author":[{"given":"Jing-Li","family":"Gan","sequence":"first","affiliation":[{"name":"*Mental Diseases Prevention and Treatment Institute of Chinese PLA; and \u2020Center for Medical Imaging, Jiaozuo, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Feng","family":"Duan","sequence":"additional","affiliation":[{"name":"*Mental Diseases Prevention and Treatment Institute of Chinese PLA; and \u2020Center for Medical Imaging, Jiaozuo, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Xiang","family":"Cheng","sequence":"additional","affiliation":[{"name":"*Mental Diseases Prevention and Treatment Institute of Chinese PLA; and \u2020Center for Medical Imaging, Jiaozuo, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ming","family":"Yang","sequence":"additional","affiliation":[{"name":"*Mental Diseases Prevention and Treatment Institute of Chinese PLA; and \u2020Center for Medical Imaging, Jiaozuo, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Quan","family":"Zhu","sequence":"additional","affiliation":[{"name":"*Mental Diseases Prevention and Treatment Institute of Chinese PLA; and \u2020Center for Medical Imaging, Jiaozuo, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cun-You","family":"Gao","sequence":"additional","affiliation":[{"name":"*Mental Diseases Prevention and Treatment Institute of Chinese PLA; and \u2020Center for Medical Imaging, Jiaozuo, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan-Min","family":"Zhao","sequence":"additional","affiliation":[{"name":"*Mental Diseases Prevention and Treatment Institute of Chinese PLA; and \u2020Center for Medical Imaging, Jiaozuo, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Jun","family":"Liang","sequence":"additional","affiliation":[{"name":"*Mental Diseases Prevention and Treatment Institute of Chinese PLA; and \u2020Center for Medical Imaging, Jiaozuo, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib2-20230928","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1523\/JNEUROSCI.5377-03.2004","article-title":"Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways","volume":"24","year":"2004","journal-title":"J Neurosci"},{"key":"bib3-20230928","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0920-9964(01)00155-4","article-title":"Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation","volume":"52","year":"2001","journal-title":"Schizophr Res"},{"key":"bib4-20230928","doi-asserted-by":"crossref","first-page":"105","DOI":"10.31887\/DCNS.2008.10.1\/tcbaghai","article-title":"Electroconvulsive therapy and its different indications","volume":"10","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"key":"bib5-20230928","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/j.1460-2075.1982.tb01207.x","article-title":"Purification of a new neurotrophic factor from mammalian brain","volume":"1","year":"1982","journal-title":"EMBO J"},{"key":"bib6-20230928","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.biopsych.2010.10.004","article-title":"Proton magnetic resonance spectroscopy and illness stage in schizophrenia\u2014a systematic review and meta-analysis","volume":"69","year":"2011","journal-title":"Biol Psychiatry"},{"key":"bib7-20230928","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/mp.2009.121","article-title":"1H-MRS at 4 tesla in minimally treated early schizophrenia","volume":"15","year":"2010","journal-title":"Mol Psychiatry"},{"key":"bib8-20230928","first-page":"129","article-title":"Complications in major depressive disorder therapy: A review of magnetic resonance spectroscopy studies","volume":"23","year":"2008","journal-title":"Funct Neurol"},{"key":"bib9-20230928","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00124509-200103000-00006","article-title":"ECS-induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment","volume":"17","year":"2001","journal-title":"J ECT"},{"key":"bib10-20230928","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/cap.2011.0012","article-title":"Two-year follow-up of cognitive functions in schizophrenia spectrum disorders of adolescent patients treated with electroconvulsive therapy","volume":"21","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"bib11-20230928","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","article-title":"A molecular and cellular theory of depression","volume":"54","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"bib12-20230928","first-page":"181","article-title":"Molecular and cellular actions of chronic electroconvulsive seizures","volume":"14","year":"1998","journal-title":"J ECT"},{"key":"bib13-20230928","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00406-003-0398-5","article-title":"Multiregional 1H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia","volume":"253","year":"2003","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"bib14-20230928","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainres.2011.06.052","article-title":"Asymmetric alternation of the hemodynamic response at the prefrontal cortex in patients with schizophrenia during electroconvulsive therapy: A near-infrared spectroscopy study","volume":"1410","year":"2011","journal-title":"Brain Res"},{"key":"bib15-20230928","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pscychresns.2014.04.010","article-title":"Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study","volume":"223","year":"2014","journal-title":"Psychiatry Res"},{"key":"bib16-20230928","first-page":"654","article-title":"Study on gender differences in proton magnetic resonance spectroscopy of the prefrontal lobe and thalamus in first-episode schizophrenics","volume":"36","year":"2010","journal-title":"Chin J Nerv Ment Dis"},{"key":"bib17-20230928","first-page":"641","article-title":"Quality of life after electroconvulsive therapy in persons with treatment resistant schizophrenia","volume":"133","year":"2011","journal-title":"Indian J Med Res"},{"key":"bib18-20230928","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0005-2736(91)90362-C","article-title":"Proton nuclear magnetic resonance studies on the molecular dynamics of plasmenylcholine\/cholesterol and phosphatidylcholine\/cholesterol bilayers","volume":"1063","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"bib19-20230928","doi-asserted-by":"crossref","first-page":"333","DOI":"10.31887\/DCNS.2009.11.3\/jhunsberger","article-title":"The neurotrophic and neuroprotective effects of psychotropic agents","volume":"11","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"bib20-20230928","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.schres.2005.02.012","article-title":"N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI","volume":"76","year":"2005","journal-title":"Schizophr Res"},{"key":"bib21-20230928","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/acps.12462","article-title":"Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression","volume":"133","year":"2016","journal-title":"Acta Psychiatr Scand"},{"key":"bib22-20230928","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","year":"1987","journal-title":"Schizophr Bull"},{"key":"bib23-20230928","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00406-009-0033-1","article-title":"Risperidone and haloperidol promote survival of stem cells in the rat hippocampus","volume":"260","year":"2010","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"bib24-20230928","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroimage.2010.06.006","article-title":"Interaction of hippocampal volume and N-acetylaspartate concentration deficits in schizophrenia: A combined MRI and 1H-MRS study","volume":"53","year":"2010","journal-title":"Neuroimage"},{"key":"bib25-20230928","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pscychresns.2012.02.003","article-title":"Neurometabolites in schizophrenia and bipolar disorder\u2014a systematic review and meta-analysis","volume":"203","year":"2012","journal-title":"Psychiatry Res"},{"key":"bib26-20230928","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopsych.2007.01.002","article-title":"Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity","volume":"62","year":"2007","journal-title":"Biol Psychiatry"},{"key":"bib27-20230928","first-page":"501","article-title":"Use of ECT in drug-refractory schizophrenia\u2013a survey of the current literature","volume":"80","year":"2012","journal-title":"Fortschr Neurol Psychiatr"},{"key":"bib28-20230928","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.ne.19.030196.001445","article-title":"Physiology of the neurotrophins","volume":"19","year":"1996","journal-title":"Annu Rev Neurosci"},{"key":"bib29-20230928","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0306-4522(00)00078-6","article-title":"Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus","volume":"98","year":"2000","journal-title":"Neuroscience"},{"key":"bib30-20230928","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/YCT.0b013e318205e1c0","article-title":"Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms","volume":"27","year":"2011","journal-title":"J ECT"},{"key":"bib31-20230928","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1017\/S0033291703007931","article-title":"Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression","volume":"33","year":"2003","journal-title":"Psychol Med"},{"key":"bib32-20230928","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/schbul\/sbt124","article-title":"reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia","volume":"40","year":"2014","journal-title":"Schizophr Bull"},{"key":"bib33-20230928","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","year":"1995","journal-title":"J Neurosci"},{"key":"bib34-20230928","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.schres.2008.08.005","article-title":"Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy","volume":"106","year":"2008","journal-title":"Schizophr Res"},{"key":"bib35-20230928","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jpsychires.2006.07.002","article-title":"Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: A proton magnetic resonance spectroscopy study","volume":"41","year":"2007","journal-title":"J Psychiatr Res"},{"key":"bib36-20230928","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.euroneuro.2008.12.012","article-title":"Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells","volume":"19","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"bib37-20230928","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jpsychires.2010.05.001","article-title":"Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder","volume":"45","year":"2011","journal-title":"J Psychiatr Res"},{"key":"bib38-20230928","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S0041-87812004000300010","article-title":"Proton magnetic resonance spectroscopy of the frontal lobe in schizophrenics: A critical review of the methodology","volume":"59","year":"2004","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"key":"bib39-20230928","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0920-9964(02)00533-9","article-title":"Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: A proton magnetic resonance spectroscopy study","volume":"64","year":"2003","journal-title":"Schizophr Res"},{"key":"bib40-20230928","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/sj.npp.1300850","article-title":"Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: A systematic review and meta-analysis","volume":"30","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"bib41-20230928","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0031-1279739","article-title":"Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment","volume":"44","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"bib42-20230928","first-page":"414","article-title":"Proton magnetic resonance spectroscopy changes after antipsychotic treatment","volume":"20","year":"2013","journal-title":"Curr Med Chem"},{"key":"bib43-20230928","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1440-1819.2006.01515.x","article-title":"Quantitative magnetic resonance spectroscopy of schizophrenia: Relationship between decreased N-acetylaspartate and frontal lobe dysfunction","volume":"60","year":"2006","journal-title":"Psychiatry Clin Neurosci"},{"key":"bib44-20230928","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jpsychires.2011.02.004","article-title":"1 H-MR spectroscopy in ultra-high risk and first episode stages of schizophrenia","volume":"45","year":"2011","journal-title":"J Psychiatr Res"},{"key":"bib45-20230928","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/YCT.0b013e3182887a1a","article-title":"Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy","volume":"29","year":"2013","journal-title":"J ECT"}],"container-title":["Journal of Nervous &amp; Mental Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005053-201706000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T23:13:08Z","timestamp":1695942788000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005053-201706000-00010"}},"subtitle":["A Proton Magnetic Resonance Spectroscopy Study"],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/nmd.0000000000000652","relation":{},"ISSN":["1539-736X","0022-3018"],"issn-type":[{"value":"1539-736X","type":"electronic"},{"value":"0022-3018","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}